Category: HIV
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.
Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve c
For thousands of years an undesirable and persistent companion has been travelling with man wherever he goes.
DETROIT -- A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer -- and that only age is a contributing factor.
Researchers have shown how an antiviral protein produced by the immune system, dubbed tetherin, tames HIV and other viruses by literally putting them on a leash, to prevent their escape from infect
LOS ALAMOS, New Mexico, October 27, 2009 -- Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using t
HOUSTON - Drawing on years of experience in cancer research and patient care, The University of Texas M. D.
Sperm, and not just the fluid it bathes in, can transmit HIV to macrophages, T cells, and dendritic cells (DCs), report a team led by Ana Ceballos at the University of Buenos Aires in Argentina.
Genes May Determine Susceptibility to H5N1 Avian Influenza A Virus Infection
PROVIDENCE, R.I. [Brown University] -- Contrary to conventional wisdom, scientific evidence proving that overlapping multiple sexual partners -- concurrency -- drives the HIV epidemic in sub-Saharan Africa is actually quite limited, Brown University researchers have concluded.
Arlington, Va. -- Medical providers on the front lines of HIV care applaud the U.S. Congress for extending the Ryan White HIV/AIDS Program, helping to ensure that more than half a million low-income, uninsured, or underinsured people living with HIV/AIDS have access to lifesaving care.
The feeling of stigmatization that people living with HIV often experience doesn't only exact a psychological toll -- new UCLA research suggests it can also lead to quantifiably negative health outcomes.
Yesterday saw the release of the paper published in the New England Journal of Medicine containing the hotly awaited data concerning the RV144 HIV vaccine trial that took place in Thailand. There was already some discussion of the initial results, which were reported in September and discussed by Colin and Martin. As has already been discussed, there is a very cautious consensus due to the statistical analysis of the trial only *just* falling on the side of significant. Click here to read this post in its native environment, on Blue-Genes.net.
Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding, according to a new study. The findings, now available online in the Nov.
